WallStSmart

Churchill Capital Corp XI (CCXI)vsIllumination Acquisition Corp I Class A Ordinary Shares (ILLU)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

ILLU leads profitability with a 0.0% profit margin vs 0.0%. ILLU earns a higher WallStSmart Score of 23/100 (F).

CCXI

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 4.0
Piotroski: 2/9

ILLU

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

ILLU1 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$718.53M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

ILLU4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$312.29M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : ILLU

The strongest argument for ILLU centers on Price/Book.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : ILLU

The primary concerns for ILLU are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

ILLU is growing revenue faster at 0.0% — sustainability is the question.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (23/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Illumination Acquisition Corp I Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

Illumination Acquisition Corp I (ILLU) is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative businesses primarily in the technology and healthcare sectors. With a seasoned management team that possesses deep industry expertise and extensive networks, ILLU is well-positioned to uncover high-potential investment opportunities that can drive substantial value creation. The company aims to capitalize on emerging trends and transformative shifts within these dynamic industries, fostering innovation and sustained growth for its stakeholders.

Want to dig deeper into these stocks?